| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.749 | 12.305 | 15.131 | 3.328 | 316 | 0 | 0 | 0 | 3.122 | 735 |
| Total Income - EUR | 14.750 | 12.307 | 15.132 | 3.328 | 316 | 0 | 0 | 0 | 3.122 | 735 |
| Total Expenses - EUR | 13.811 | 12.031 | 11.118 | 4.366 | 1.104 | 333 | 0 | 0 | 1.879 | 1.196 |
| Gross Profit/Loss - EUR | 939 | 276 | 4.014 | -1.037 | -788 | -333 | 0 | 0 | 1.243 | -461 |
| Net Profit/Loss - EUR | 497 | 89 | 3.863 | -1.071 | -798 | -333 | 0 | 0 | 1.032 | -461 |
| Employees | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tucan Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.315 | 3.614 | 1.934 | 434 | 339 | 0 | 0 | 0 | 719 | 447 |
| Current Assets | 5.445 | 2.115 | 5.076 | 1.116 | 67 | 0 | 0 | 0 | 1.768 | 862 |
| Inventories | 1.063 | 1.052 | 1.057 | 1.038 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.111 | 0 | 1.650 | 0 | 0 | 0 | 0 | 0 | 283 | 236 |
| Cash | 3.270 | 1.062 | 2.368 | 78 | 67 | 0 | 0 | 0 | 1.485 | 626 |
| Shareholders Funds | 551 | 142 | 3.916 | -1.019 | -1.797 | -2.096 | -2.050 | -2.056 | -1.018 | -1.474 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 10.209 | 5.586 | 3.094 | 2.569 | 2.203 | 2.096 | 2.050 | 2.056 | 3.506 | 2.782 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Tucan Med Srl